{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:02:33Z","timestamp":1790701353751,"version":"4.1.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007723","name":"Takeda Pharmaceutical Company Limited","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007723","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Koa Webster"},{"name":"Prudence Stanford"},{"name":"Envision Ignite"},{"name":"Envision Medical Communications agency"},{"name":"Envision Pharma Group"},{"DOI":"10.13039\/100007723","name":"Takeda Pharmaceutical Company Limited","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007723","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Good Publication Practice"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background\/Aims<\/jats:title>\n                    <jats:p>Darvadstrocel is a 1-time local injection for treatment-refractory complex perianal fistulas in patients with Crohn\u2019s disease. Here we present 3-year (week 156) follow-up results from a Japanese phase 3, multicenter, open-label study of darvadstrocel.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Adult Japanese patients with Crohn\u2019s disease and complex perianal fistulas refractory to previous treatment were treated with darvadstrocel after fistula curettage and seton placement. In this long-term follow-up extension, treatment-emergent adverse events, including serious treatment-emergent adverse events, were recorded through week 156. The proportions of patients with combined remission (clinical remission plus magnetic resonance imaging confirmation of fistula closure) and clinical remission were recorded at week 104 and week 156.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In total, 22 patients were treated with darvadstrocel; 19 patients completed assessment at week 156. Through week 156, treatment-emergent adverse events were experienced by 21\/22 patients (95.5%); most treatment-emergent adverse events were moderate (40.9%) or mild (31.8%). Serious treatment-emergent adverse events were reported in 11 patients (50.0%). At week 104 and week 156, 77.3% of patients (17\/22) and 68.2% of patients (15\/22), respectively, achieved both combined and clinical remission. Mean maximum short axis diameter of the fistula tract at the time of remission was shortest in patients who maintained combined remission until week 156.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>No new safety signals for darvadstrocel were identified during the 3-year follow-up period. Combined and clinical remission of complex perianal fistulas was sustained up to 156\u2009weeks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>ClinicalTrials.gov registration<\/jats:title>\n                    <jats:p>NCT03706456.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/crocol\/otag090","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T11:20:05Z","timestamp":1786965605000},"source":"Crossref","is-referenced-by-count":0,"title":["Long-term safety and efficacy of darvadstrocel for complex perianal fistulas in Japanese adults with Crohn\u2019s disease: 3-year follow-up results"],"prefix":"10.1093","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0825-6823","authenticated-orcid":false,"given":"Tsunekazu","family":"Mizushima","sequence":"first","affiliation":[{"name":"Department of Colorectal Surgery, Dokkyo Medical University , Mibu,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satomi","family":"Furukawa","sequence":"additional","affiliation":[{"name":"Department of Coloproctology, JCHO Tokyo Yamate Medical Center , Tokyo,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikisaburo","family":"Sahara","sequence":"additional","affiliation":[{"name":"Department of Proctology, Makita General Hospital , Tokyo,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Ohta","sequence":"additional","affiliation":[{"name":"Department of Coloproctology, Ieda Hospital , Toyota,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8040-4854","authenticated-orcid":false,"given":"Yoshiki","family":"Okita","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal and Pediatric Surgery, Mie University Graduate School of Medicine , Tsu,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Ito","sequence":"additional","affiliation":[{"name":"IBD Center, Sapporo Higashi Tokushukai Hospital , Sapporo,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Ikeuchi","sequence":"additional","affiliation":[{"name":"Department of Inflammatory Bowel Disease Surgery, Hyogo Medical University , Hyogo,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daijiro","family":"Higashi","sequence":"additional","affiliation":[{"name":"Department of Surgery, Fukuoka University Chikushi Hospital , Chikushino,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Sugita","sequence":"additional","affiliation":[{"name":"Department of Inflammatory Bowel Disease, Yokohama Municipal Citizens Hospital , Yokohama,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Inflammatory Bowel Disease Center, Tohoku Rosai Hospital , Sendai,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5435-4144","authenticated-orcid":false,"given":"Takayuki","family":"Ogino","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Graduate School of Medicine, The University of Osaka , Osaka,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Kiryu","sequence":"additional","affiliation":[{"name":"Department of Radiology, International University of Health and Welfare Narita Hospital , Narita,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Nakaya","sequence":"additional","affiliation":[{"name":"Takeda Development Center Japan, Takeda Pharmaceutical Company Limited , Osaka,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Narii","sequence":"additional","affiliation":[{"name":"Takeda Development Center Japan, Takeda Pharmaceutical Company Limited , Osaka,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayoshi","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Takeda Development Center Japan, Takeda Pharmaceutical Company Limited , Osaka,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine for Inflammatory Bowel Disease, The University of Toyama , Toyama,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kitaro","family":"Futami","sequence":"additional","affiliation":[{"name":"Department of Surgery, Matsunaga Hospital , Fukuoka,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"2026092912181287000_otag090-B1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.5217\/ir.2016.14.2.111","article-title":"Changing epidemiological trends of inflammatory bowel disease in Asia","volume":"14","author":"Ng","year":"2016","journal-title":"Intest Res"},{"key":"2026092912181287000_otag090-B2","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1053\/gast.2002.32362","article-title":"The natural history of fistulizing Crohn\u2019s disease in Olmsted County, Minnesota","volume":"122","author":"Schwartz","year":"2002","journal-title":"Gastroenterology"},{"key":"2026092912181287000_otag090-B3","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1136\/gutjnl-2017-314918","article-title":"Modern management of perianal fistulas in Crohn\u2019s disease: future directions","volume":"67","author":"Kotze","year":"2018","journal-title":"Gut"},{"key":"2026092912181287000_otag090-B4","doi-asserted-by":"publisher","first-page":"544","DOI":"10.5009\/gnl18157","article-title":"Association of perianal fistulas with clinical features and prognosis of Crohn\u2019s disease in Korea: results from the CONNECT study","volume":"12","author":"Chun","year":"2018","journal-title":"Gut Liver"},{"key":"2026092912181287000_otag090-B5","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1093\/ecco-jcc\/jjad038","article-title":"Diagnosis and clinical features of perianal lesions in newly diagnosed Crohn\u2019s disease: subgroup analysis from Inception Cohort Registry Study of Patients with Crohn\u2019s Disease (iCREST-CD)","volume":"17","author":"Yamamoto","year":"2023","journal-title":"J Crohns Colitis"},{"key":"2026092912181287000_otag090-B6","doi-asserted-by":"publisher","first-page":"otab055","DOI":"10.1093\/crocol\/otab055","article-title":"Diagnostic features of perianal fistula in patients with Crohn\u2019s disease: analysis of a Japanese claims database","volume":"3","author":"Mizushima","year":"2021","journal-title":"Crohns Colitis 360"},{"key":"2026092912181287000_otag090-B7","first-page":"437","article-title":"Treatment for perianal Crohn\u2019s disease [in Japanese]","volume":"70","author":"Futami","year":"2012","journal-title":"Nihon Rinsho"},{"key":"2026092912181287000_otag090-B8","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.gastha.2023.08.011","article-title":"Observational burden of illness study in patients with Crohn\u2019s disease with and without perianal fistulas in the United States","volume":"2","author":"Jiang","year":"2023","journal-title":"Gastro Hep Adv"},{"key":"2026092912181287000_otag090-B9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3862\/jcoloproctology.77.89","article-title":"Effect of perianal fistula on the quality of life and work productivity of patients with Crohn\u2019s disease: report of a questionnaire survey [in Japanese]","volume":"77","author":"Saigusa","year":"2024","journal-title":"Nihon Daicho Komonbyo Gakkai Zasshi"},{"key":"2026092912181287000_otag090-B10","first-page":"87","article-title":"Surgical treatment for perianal Crohn\u2019s disease [in Japanese]","volume":"116","author":"Futami","year":"2015","journal-title":"Nihon Geka Gakkai Zasshi"},{"key":"2026092912181287000_otag090-B11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/ecco-jcc\/jjz187","article-title":"ECCO guidelines on therapeutics in Crohn\u2019s disease: surgical treatment","volume":"14","author":"Adamina","year":"2020","journal-title":"J Crohns Colitis"},{"key":"2026092912181287000_otag090-B12","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1093\/ecco-jcc\/jjae089","article-title":"ECCO guidelines on therapeutics in Crohn\u2019s disease: surgical treatment","volume":"18","author":"Adamina","year":"2024","journal-title":"J Crohns Colitis"},{"key":"2026092912181287000_otag090-B13","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1186\/s12955-020-01622-7","article-title":"Burden of disease and adaptation to life in patients with Crohn\u2019s perianal fistula: a qualitative exploration","volume":"18","author":"Adegbola","year":"2020","journal-title":"Health Qual Life Outcomes"},{"key":"2026092912181287000_otag090-B14","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1056\/NEJMoa030815","article-title":"Infliximab maintenance therapy for fistulizing Crohn\u2019s disease","volume":"350","author":"Sands","year":"2004","journal-title":"N Engl J Med"},{"key":"2026092912181287000_otag090-B15","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.cgh.2024.08.032","article-title":"Efficacy and safety of upadacitinib for perianal fistulizing Crohn\u2019s disease: a post hoc analysis of 3 phase 3 trials","volume":"23","author":"Colombel","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026092912181287000_otag090-B16","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/S0140-6736(16)31203-X","article-title":"Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn\u2019s disease: a phase 3 randomised, double-blind controlled trial","volume":"388","author":"Pan\u00e9s","year":"2016","journal-title":"Lancet"},{"key":"2026092912181287000_otag090-B17","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1053\/j.gastro.2017.12.020","article-title":"Long-term efficacy and safety of stem cell therapy (Cx601) for complex perianal fistulas in patients with Crohn\u2019s disease","volume":"154","author":"Pan\u00e9s","year":"2018","journal-title":"Gastroenterology"},{"key":"2026092912181287000_otag090-B18","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/ueg2.12673","article-title":"Darvadstrocel for complex perianal fistulas in Crohn\u2019s disease: a systematic review and meta-analysis","volume":"13","author":"Taxonera","year":"2025","journal-title":"United European Gastroenterol J"},{"key":"2026092912181287000_otag090-B19","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1093\/ecco-jcc\/jjac144","article-title":"Darvadstrocel for complex perianal fistulas in Japanese adults with Crohn\u2019s disease: a phase 3 study","volume":"17","author":"Furukawa","year":"2023","journal-title":"J Crohns Colitis"},{"key":"2026092912181287000_otag090-B20","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1097\/DCR.0000000000002325","article-title":"Follow-up study to evaluate the long-term safety and efficacy of darvadstrocel (mesenchymal stem cell treatment) in patients with perianal fistulizing Crohn\u2019s disease: ADMIRE-CD phase 3 randomized controlled trial","volume":"65","author":"Garcia-Olmo","year":"2022","journal-title":"Dis Colon Rectum"},{"key":"2026092912181287000_otag090-B21","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1053\/j.gastro.2025.12.033","article-title":"Darvadstrocel in patients with Crohn\u2019s disease with complex perianal fistulas: the ADMIRE CD II phase 3 randomized trial","volume":"170","author":"Colombel","year":"2026","journal-title":"Gastroenterology"},{"key":"2026092912181287000_otag090-B22","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1093\/ibd\/izab361","article-title":"INSPECT: a retrospective study to evaluate long-term effectiveness and safety of darvadstrocel in patients with perianal fistulizing Crohn\u2019s disease treated in the ADMIRE-CD trial","volume":"28","author":"Pan\u00e9s","year":"2022","journal-title":"Inflamm Bowel Dis"},{"key":"2026092912181287000_otag090-B23","doi-asserted-by":"crossref","first-page":"i192","DOI":"10.1093\/ecco-jcc\/jjad212.0106","article-title":"DOP66 INSPIRE: preliminary data from an observational post-marketing registry on the effectiveness and safety of darvadstrocel in patients with Crohn\u2019s disease and complex perianal fistulas","volume":"18","author":"Fathallah","year":"2024","journal-title":"J Crohns Colitis"},{"key":"2026092912181287000_otag090-B24","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/codi.16830","article-title":"Mesenchymal stem cell therapy for Crohn\u2019s perianal fistula-a real-world experience","volume":"26","author":"White","year":"2024","journal-title":"Colorectal Dis"},{"key":"2026092912181287000_otag090-B25","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/ecco-jcc\/jjy113","article-title":"ECCO-ESGAR Guideline for Diagnostic Assessment in IBD part 1: Initial diagnosis, monitoring of known IBD, detection of complications","volume":"13","author":"Maaser","year":"2019","journal-title":"J Crohns Colitis"},{"key":"2026092912181287000_otag090-B26","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1136\/gutjnl-2019-320553","article-title":"Development and initial psychometric validation of a patient-reported outcome measure for Crohn\u2019s perianal fistula: the Crohn\u2019s Anal Fistula Quality of Life (CAF-QoL) scale","volume":"70","author":"Adegbola","year":"2021","journal-title":"Gut"}],"container-title":["Crohn\u2019s &amp; Colitis 360"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/crohnscolitis360\/article-pdf\/8\/3\/otag090\/70684030\/otag090.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/crohnscolitis360\/article-pdf\/8\/3\/otag090\/70684030\/otag090.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:18:18Z","timestamp":1790698698000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/crohnscolitis360\/article\/doi\/10.1093\/crocol\/otag090\/8763693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7,8]]}},"URL":"https:\/\/doi.org\/10.1093\/crocol\/otag090","relation":{},"ISSN":["2631-827X"],"issn-type":[{"value":"2631-827X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,7]]},"article-number":"otag090"}}